Cart
sales@molnova.com
DL-Buthionine-(SR)-sulfoximine
CAS No. 5072-26-4
DL-Buthionine-(SR)-sulfoximine ( Butionine sulfoximine;NSC 381100 )
Catalog No. M20963 CAS No. 5072-26-4
DL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase?for the treatment of solid tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 39 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDL-Buthionine-(SR)-sulfoximine
-
NoteResearch use only not for human use.
-
Brief DescriptionDL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase?for the treatment of solid tumors.
-
DescriptionDL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase?for the treatment of solid tumors.
-
SynonymsButionine sulfoximine;NSC 381100
-
PathwayOthers
-
TargetOther Targets
-
Recptorγ-glutamylcysteine synthetase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5072-26-4
-
Formula Weight222.31
-
Molecular FormulaC8H18N2O3S
-
Purity>98% (HPLC)
-
SolubilityH2O:41.67 mg/mL (187.44 mM; Need ultrasonic)
-
SMILESCCCCS(=N)(=O)CCC(N)C(=O)O
-
Chemical Name2-amino-4-(butylsulfonimidoyl)butanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arrick B. A . Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis[J]. Journal of Experimental Medicine 1981 153(3):720-725.
molnova catalog
related products
-
Verdiperstat
Verdiperstat (AZD-3241) is a potent, selective, reversible, orally active myeloperoxidase (MPO) inhibitor with IC50 of 630 nM, >14-fold selectivity over thyroid peroxidase (TPO).
-
A-71915 TFA (132956-...
A-71915 (TFA) is a selective inhibitor of ANP receptor (atrial natriuretic peptide-receptor), induces apoptosis and decreases insulin secretion in RINm5F pancreatic β-cells.
-
Urantide
Selective and competitive urotensin-II (UT) receptor antagonist (pKB = 8.3). Blocks hU-II induced contractions in thoracic aorta ex vivo. Exhibits no effect on noradrenaline or endothelin 1-induced contraction or on acetylcholine-induced relaxation. Behaves as a partial agonist in a calcium mobilization assay (in CHO cells expressing hUT receptors).
